This study examines vertical and horizontal tongue body movements in VCV sequences, where the consonant is a voiced or voiceless velar stop. The movement data were recorded using a magnetic transduction technique in two subjects. Consistent with studies of lip and jaw kinematics, the duration of the tongue body raising movement towards closure for the consonant was longer for the voiced stop. In contrast to lip and jaw movements, peak velocity and amplitude of the raising movements were consistently higher for the voiced stop. The larger displacement of the closing movement for the voiced stop was due to a lower starting position of the movement during the preceding vowel. Examination of the tongue body lowering movement for the vowel preceding the velar stop showed it to be longer when the following stop was voiced. Also this lowering movement had a higher peak velocity and amplitude in the voiced environment. These results thus suggest that both the lowering and raising movements in the VC sequence are affected by the voicing status of the consonant. In addition, the second vowel in the VCV sequence showed reliable influences on tongue body movements for the first vowel and the consonant.

This content is only available via PDF.
© 1994 S. Karger AG, Basel
1994
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.